Affiliation:
1. Division of Cardiac Surgery, Brigham and Women’s Hospital, Harvard Medical School , Boston, MA, USA
2. Albany Medical College , Albany, NY, USA
Abstract
Abstract
OBJECTIVES
Mitral valve repair (MVP) is the gold standard treatment for degenerative mitral regurgitation. With the expansion of transcatheter technologies, this study compares the outcome of MVP in low-risk and non-low-risk patients to serve as a benchmark.
METHODS
This retrospective, single-institution study examined all patients who underwent MVP for primary mitral regurgitation from 2005 to 2018. Patients were stratified into 2 risk categories: low-risk [Society of Thoracic Surgeons (STS) Predicted Risk of Mortality (STS-PROM) ≤2%] and non-low risk (STS-PROM > 2% or age > 75), with a subgroup of very low risk (STS-PROM ≤1%, age <75).
RESULTS
A total of 1207 patients were included, and 1053 patients were classified as low risk and 154 as non-low risk. The non-low-risk group was significantly older, more likely to be female, and had a higher comorbidity burden than the low-risk group (all P < 0.01). For the low-risk group, the observed-to-expected (O:E) STS mortality ratio was 0.4 and the composite morbidity and mortality ratio was 0.6, whereas for the non-low risk, the O:E mortality was 1.5 and the composite morbidity and mortality was 0.9. When the subgroup of very low-risk group was assessed, the mortality O:E ratio was 0.
CONCLUSIONS
The observed composite morbidity and mortality of patients undergoing MVP were persistently lower in low-risk patients, mainly driven by the very low-risk group. The excellent outcome of MVP in low-risk patients should be validated on a national level to determine how transcatheter technologies can be utilized in these patients.
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery
Reference19 articles.
1. Burden of valvular heart diseases: a population-based study;Nkomo;Lancet,2006
2. Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients;David;J Thorac Cardiovasc Surg,2003
3. Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop?;Gillinov;Ann Thorac Surg,2010
4. Isolated mitral valve surgery risk in 77,836 patients from the Society of Thoracic Surgeons database;Chatterjee;Ann Thorac Surg,2013
5. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Otto;Circulation,2021